chrX-47224742-T-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_006201.5(CDK16):c.461T>A(p.Leu154Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,209,769 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006201.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK16 | NM_006201.5 | c.461T>A | p.Leu154Gln | missense_variant, splice_region_variant | 4/16 | ENST00000357227.9 | NP_006192.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK16 | ENST00000357227.9 | c.461T>A | p.Leu154Gln | missense_variant, splice_region_variant | 4/16 | 1 | NM_006201.5 | ENSP00000349762.4 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111595Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33751
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182758Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67330
GnomAD4 exome AF: 0.0000173 AC: 19AN: 1098174Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 5AN XY: 363534
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111595Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33751
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2023 | The c.683T>A (p.L228Q) alteration is located in exon 4 (coding exon 4) of the CDK16 gene. This alteration results from a T to A substitution at nucleotide position 683, causing the leucine (L) at amino acid position 228 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at